Laurus Labs LtdQ2 FY24
Laurus Labs Ltd Q2 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹1,530P/E: 80.4Market Cap: ₹71.5K CrSector: Pharmaceuticals & Biotechnology
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
No information is provided regarding the same in the latest conference call.
Margin guidance
No information is provided regarding the same in the latest conference call.
3 more insights locked — sign up free to unlock
Fundraise plans
No information is provided regarding the same in the latest conference call.
Order book
No information is provided regarding the same in the latest conference call.
Capex plans
No information is provided regarding the same in the latest conference call.
How does Laurus Labs Ltd rank vs peers in Pharmaceuticals & Biotechnology?
Pro feature1Laurus Labs Ltd
See full Pharmaceuticals & Biotechnology sector rankings